Literature DB >> 7320168

Separation of bilirubin species in serum and bile by high-performance reversed-phase liquid chromatography.

J J Lauff, M E Kasper, R T Ambrose.   

Abstract

A high-performance, reversed-phase liquid chromatographic (HPLC) procedure has been developed for the separation of at least three major bilirubin fractions in bile and four fractions in human serum. This procedure was unlike most others, in that serum was not totally deproteinized prior to injection onto the HPLC column; instead, serum was treated with an excess of sodium sulfate solution to precipitate primarily proteins larger than albumin. Injection of the filtered and diluted supernatant onto a reversed-phase column then resulted in the separation of the bilirubin species in a 24-min gradient elution run. Both the initial aqueous acidic mobile phase and the final isopropyl alcohol-based mobile phase contained 5% methoxyethanol (v/v) to facilitate elution of albumin still present in the treated sample. Bilirubin species eluting from the column were detected by absorbance at 450 nm. Results of a number of chromatographic separations of pathological sera indicated a wide variation in the relative proportions of the four bilirubin fractions observed. A correlation of the sum of the areas of the bilirubin peaks observed by HPLC was found with the total bilirubin value obtained by a standard reference procedure.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7320168     DOI: 10.1016/s0378-4347(00)86073-9

Source DB:  PubMed          Journal:  J Chromatogr


  10 in total

1.  Novel assay for measuring serum conjugated bilirubin and its clinical relevance.

Authors:  Y Morimoto; T Ishihara; M Takayama; M Kaito; Y Adachi
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Cholestasis.

Authors: 
Journal:  West J Med       Date:  1983-02

3.  Enzymatic assay for conjugated bilirubin (Bc) in serum using bilirubin oxidase (BOD).

Authors:  S Kimura; S Iyama; Y Yamaguchi; S Hayashi; T Yanagihara
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

4.  Irreversible binding of conjugated bilirubin to albumin in cholestatic rats.

Authors:  A Gautam; H Seligson; E R Gordon; D Seligson; J L Boyer
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

5.  Serum bilirubin fractionation using multilayer film method in hepatobiliary diseases in comparison with high performance liquid chromatography.

Authors:  Y Adachi; H Inufusa; M Yamashita; K Ozaki; A Kanbe; T Nanno; Y Ohba; H Nakamura; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1987-10

6.  Measurement of serum bilirubin and its mono- and diconjugates: application to patients with hepatobiliary disease.

Authors:  B F Scharschmidt; N Blanckaert; F A Farina; P M Kabra; B E Stafford; R A Weisiger
Journal:  Gut       Date:  1982-08       Impact factor: 23.059

7.  Irreversible binding of zomepirac to plasma protein in vitro and in vivo.

Authors:  P C Smith; A F McDonagh; L Z Benet
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

8.  Analyses of azopigments obtained from the delta fraction of bilirubin from mammalian plasma (mammalian biliprotein).

Authors:  H Yoshida; T Inagaki; M Hirano; T Sugimoto
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

9.  Human serum bilirubin fractionation in various hepatobiliary diseases by the newly developed high performance liquid chromatography.

Authors:  Y Adachi; H Inufusa; M Yamashita; A Kambe; K Yamazaki; Y Sawada; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1988-06

10.  Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat.

Authors:  A F McDonagh; L A Palma; J J Lauff; T W Wu
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.